• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种高级别恶性小鼠B细胞淋巴瘤的特征及腹腔或静脉接种后其播散模式的研究。

Characterization of a high-grade malignant murine B-cell lymphoma and a study of its dissemination pattern after intraperitoneal or intravenous inoculation.

作者信息

Molenaar W M, Ellens H, van den Berg H M

出版信息

Invasion Metastasis. 1985;5(4):206-17.

PMID:2409045
Abstract

A high-grade malignant lymphoma that arose spontaneously in a C57BL mouse has been transplanted by intraperitoneal injection of a single cell suspension for over 20 years. In the current study it was characterized cytohistologically and immunologically and was found to be a high-grade malignant (immunoblastic) B-lymphoma. The distribution in the various organs and the peripheral blood was investigated after intraperitoneal and intravenous injection and the effect of splenectomy was studied. The findings suggest that the major initial proliferation of lymphoma cells occurs in the spleen both after intraperitoneal and intravenous injection. The second, final stage is characterized by leukemic infiltration throughout the body organs. The current observations are compared to those concerning the previously described, low-grade malignant murine BCL1-lymphoma.

摘要

一只C57BL小鼠自发产生的高级别恶性淋巴瘤,通过腹腔注射单细胞悬液已移植了20多年。在当前研究中,对其进行了细胞组织学和免疫学特征分析,发现它是一种高级别恶性(免疫母细胞性)B细胞淋巴瘤。在腹腔注射和静脉注射后,研究了淋巴瘤细胞在各个器官和外周血中的分布,并研究了脾切除的效果。研究结果表明,无论是腹腔注射还是静脉注射后,淋巴瘤细胞的主要初始增殖都发生在脾脏。第二个也是最后阶段的特征是白血病细胞浸润全身各器官。将当前的观察结果与先前描述的低级别恶性小鼠BCL1淋巴瘤的观察结果进行了比较。

相似文献

1
Characterization of a high-grade malignant murine B-cell lymphoma and a study of its dissemination pattern after intraperitoneal or intravenous inoculation.一种高级别恶性小鼠B细胞淋巴瘤的特征及腹腔或静脉接种后其播散模式的研究。
Invasion Metastasis. 1985;5(4):206-17.
2
The pathology and homing of a transplantable murine B cell leukemia (BCL1).
J Immunol. 1979 Sep;123(3):1181-8.
3
The role of the spleen in tumor growth kinetics of the murine B cell leukemia (BCL1).脾脏在小鼠B细胞白血病(BCL1)肿瘤生长动力学中的作用。
J Immunol. 1980 Feb;124(2):586-9.
4
Dissemination and proliferation of intravenously injected murine, syngeneic T lymphoma cells.
Exp Hematol. 1981 Feb;9(2):129-36.
5
Tumor dormancy. I. Regression of BCL1 tumor and induction of a dormant tumor state in mice chimeric at the major histocompatibility complex.肿瘤休眠。I. BCL1肿瘤的消退及在主要组织相容性复合体嵌合小鼠中诱导肿瘤休眠状态
J Immunol. 1986 Aug 15;137(4):1376-82.
6
[Establishment and characteristics of orthotopically transplanted model of human primary malignant spleen lymphoma in nude mice].[人原发性恶性脾脏淋巴瘤裸鼠原位移植模型的建立及特性]
Zhonghua Zhong Liu Za Zhi. 2002 May;24(3):234-8.
7
Anti-CD45 and anti-CD52 (Campath) monoclonal antibodies effectively eliminate systematically disseminated human non-Hodgkin's lymphoma B cells in Scid mice.抗CD45和抗CD52(Campath)单克隆抗体可有效清除Scid小鼠体内系统性播散的人类非霍奇金淋巴瘤B细胞。
Exp Hematol. 1996 Jul;24(8):919-26.
8
Generation of stable cellular phenotypes in a human malignant cell line conditioned by alterations in the cellular microenvironment.
Cancer Res. 1986 Feb;46(2):940-9.
9
NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).1-氨基-2,4-二溴蒽醌(CAS编号:81-49-2)在F344/N大鼠和B6C3F1小鼠中的NTP毒理学与致癌性研究(饲料喂养研究)
Natl Toxicol Program Tech Rep Ser. 1996 Aug;383:1-370.
10
Toxicology and Carcinogenesis Studies of Furosemide (CAS No. 54-31-9) in F344/N Rats and B6C3F1 Mice (Feed Studies).速尿(CAS编号:54-31-9)在F344/N大鼠和B6C3F1小鼠中的毒理学和致癌性研究(饲料研究)
Natl Toxicol Program Tech Rep Ser. 1989 May;356:1-190.

引用本文的文献

1
Murine models of B-cell lymphomas: promising tools for designing cancer therapies.B细胞淋巴瘤的小鼠模型:设计癌症治疗方法的有前景的工具。
Adv Hematol. 2012;2012:701704. doi: 10.1155/2012/701704. Epub 2012 Feb 12.